ConductScience.org, home

Paper35407641

Growth, Endocrine Features, and Growth Hormone Treatment in Noonan Syndrome.

Dahlgren J and 1 other. J Clin Med, 2022. Cited by 23 papers, by iCite.

Cite this record

ConductScience Library. Growth, Endocrine Features, and Growth Hormone Treatment in Noonan Syndrome. Papers, record 35407641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35407641

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Growth, Endocrine Features, and Growth Hormone Treatment in Noonan Syndrome.
PubMed
Journal
J Clin Med
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
2.5
iCite
Revised in PubMed
2022-04-21
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dahlgren JJovanna
2Noordam CCeeshttps://orcid.org/0000-0001-9735-5921

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References56

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118562489Long-term GH treatment improves adult height in children with Noonan syndrome with and without mutations in protein tyrosine phosphatase, non-receptor-type 11.Eur J Endocrinol2008https://conductscience.org/library/papers/18562489PubMed
229659837Noonan syndrome-causing SHP2 mutants impair ERK-dependent chondrocyte differentiation during endochondral bone growth.Hum Mol Genet2018https://conductscience.org/library/papers/29659837PubMed
325721697The impact of growth hormone therapy on adult height in noonan syndrome: a systematic review.Horm Res Paediatr2015https://conductscience.org/library/papers/25721697PubMed
414556249Adult height in Noonan syndrome.Am J Med Genet A2003https://conductscience.org/library/papers/14556249PubMed
533795686Activating mutations in BRAF disrupt the hypothalamo-pituitary axis leading to hypopituitarism in mice and humans.Nat Commun2021https://conductscience.org/library/papers/33795686PubMed
634858328GH Responsiveness in Children With Noonan Syndrome Compared to Turner Syndrome.Front Endocrinol (Lausanne)2021https://conductscience.org/library/papers/34858328PubMed
726377682Occurrence of DNET and other brain tumors in Noonan syndrome warrants caution with growth hormone therapy.Am J Med Genet A2016https://conductscience.org/library/papers/26377682PubMed
816203673Improved final height with long-term growth hormone treatment in Noonan syndrome.Acta Paediatr2005https://conductscience.org/library/papers/16203673PubMed
922488759Autoimmune disease and multiple autoantibodies in 42 patients with RASopathies.Am J Med Genet A2012https://conductscience.org/library/papers/22488759PubMed
1020029235Noonan syndrome: growth to growth hormone - the experience of observational studies.Horm Res2009https://conductscience.org/library/papers/20029235PubMed
1131115195Molecular Genetics of Noonan Syndrome and RASopathies.Pediatr Endocrinol Rev2019https://conductscience.org/library/papers/31115195PubMed
128627463Growth hormone treatment in Noonan syndrome: the National Cooperative Growth Study experience.J Pediatr1996https://conductscience.org/library/papers/8627463PubMed
1319189703Impaired Sertoli cell function in males diagnosed with Noonan syndrome.J Pediatr Endocrinol Metab2008https://conductscience.org/library/papers/19189703PubMed
1420029233Noonan syndrome: the hypothalamo-adrenal and hypothalamo-gonadal axes.Horm Res2009https://conductscience.org/library/papers/20029233PubMed
1529575624First-year growth in children with Noonan syndrome: Associated with feeding problems?Am J Med Genet A2018https://conductscience.org/library/papers/29575624PubMed
163895929Noonan syndrome: a review.Am J Med Genet1985https://conductscience.org/library/papers/3895929PubMed
1728187225Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study.J Clin Endocrinol Metab2017https://conductscience.org/library/papers/28187225PubMed
181543375A clinical study of Noonan syndrome.Arch Dis Child1992https://conductscience.org/library/papers/1543375PubMed
1921068439Development of severe skeletal defects in induced SHP-2-deficient adult mice: a model of skeletal malformation in humans with SHP-2 mutations.Dis Model Mech2011https://conductscience.org/library/papers/21068439PubMed
2011344190Growth hormone therapy and growth in children with Noonan's syndrome: results of 3 years' follow-up.J Clin Endocrinol Metab2001https://conductscience.org/library/papers/11344190PubMed

See all 56 referencesDownload CSV of references

Cited by22

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
42882023The Diverse Clinical Spectrum of Noonan Syndrome in Pediatric Endocrinology: From Classical to Atypical Phenotypes.J Clin Med2026https://conductscience.org/library/papers/42882023PubMed
42788125Growth Outcomes and Safety of Recombinant Growth Hormone in Noonan Syndrome: A Systematic Review and Meta-Analysis.Indian J Endocrinol Metab2026https://conductscience.org/library/papers/42788125PubMed
42665698Cranial pathologies in Noonan syndrome: clinical implications for pre-growth hormone neuroimaging.Eur J Pediatr2026https://conductscience.org/library/papers/42665698PubMed
42193013Molecular Advances in Juvenile Myelomonocytic Leukemia and Associated RASopathy.Cancers (Basel)2026https://conductscience.org/library/papers/42193013PubMed
42051956Case Report: Possible improvement of near-adult height with PEG-rhGH and letrozole in a late-puberty boy with atypical Noonan syndrome and bone age/height age discrepancy: a novel therapy.Front Pediatr2026https://conductscience.org/library/papers/42051956PubMed
41988663Clinical and Genetic Characterization of Noonan Syndrome in a Colombian Pediatric CohortJ Clin Res Pediatr Endocrinol2026https://conductscience.org/library/papers/41988663PubMed
41898889Genetic Mutations Underlying Growth Impairment and Cardiomyopathies in Children: Molecular Mechanisms, Clinical Implications and Targeted Therapies.Genes (Basel)2026https://conductscience.org/library/papers/41898889PubMed
41420850Real-World Evidence of Treatment Patterns and Costs of Turner Syndrome and Noonan Syndrome in the USA.Horm Res Paediatr2025https://conductscience.org/library/papers/41420850PubMed
41285480Long-term effectiveness and safety of daily growth hormone therapy in Japanese children with Noonan syndrome: a post-marketing surveillance study.Endocr J2026https://conductscience.org/library/papers/41285480PubMed
40949923Noonan syndrome with PTPN11 gene variant presenting as isolated short stature: a case report.Transl Pediatr2025https://conductscience.org/library/papers/40949923PubMed
39825649[Growth and development patterns of Noonan syndrome and advances in the treatment of short stature].Zhongguo Dang Dai Er Ke Za Zhi2025https://conductscience.org/library/papers/39825649PubMed
39657042[Diagnostic and therapeutic perspectives in RASopathies].Magy Onkol2024https://conductscience.org/library/papers/39657042PubMed
39290328Minimizing unnecessary brain magnetic resonance imaging in pediatric endocrinology: a retrospective cohort analysis.Front Endocrinol (Lausanne)2024https://conductscience.org/library/papers/39290328PubMed
39158594Effect of long-acting PEGylated growth hormone for catch-up growth in children with idiopathic short stature: a 2-year real-world retrospective cohort study.Eur J Pediatr2024https://conductscience.org/library/papers/39158594PubMed
38964306Noonan Syndrome Growth Charts and Genotypes: 15-Year Longitudinal Single-Centre Study.Horm Res Paediatr2025https://conductscience.org/library/papers/38964306PubMed
38550930Precision diagnostics in children.Camb Prism Precis Med2023https://conductscience.org/library/papers/38550930PubMed
38463782Phenotypic and genotypic spectrum of noonan syndrome: A retrospective analysis of 46 consecutive pediatric patients presented at a regional cardiac center in China.Heliyon2024https://conductscience.org/library/papers/38463782PubMed
38454934
Safety and Effectiveness of a Biosimilar Recombinant Human Growth Hormone in Children Requiring Growth Hormone Treatment: Analysis of Final Data from PATRO Children, an International, Post-Marketing Surveillance Study.
Drug Des Devel Ther2024https://conductscience.org/library/papers/38454934PubMed
38313927Hashimoto's Thyroiditis in Noonan Syndrome: A Case Report.Cureus2024https://conductscience.org/library/papers/38313927PubMed
37964950Skeletal defects and bone metabolism in Noonan, Costello and cardio-facio-cutaneous syndromes.Front Endocrinol (Lausanne)2023https://conductscience.org/library/papers/37964950PubMed

See all 22 cited byDownload CSV of cited by

Genes11

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35407641

GET https://conductscience.org/api/papers/v1/35407641/references?page=2